Q32 Bio (QTTB) Interest & Investment Income (2017 - 2023)
Q32 Bio's (QTTB) quarterly Interest & Investment Income came in at $1.2 million in Q4 2023, down 18.97% year-on-year from $1.5 million in Q4 2022, and down 17.15% quarter-over-quarter from $1.4 million in Q3 2023.
Q32 Bio (QTTB) Interest & Investment Income (2017 - 2023) Analysis & Trends
Q32 Bio's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.2 million for Q4 2023.
- On a quarterly basis, Interest & Investment Income fell 18.97% year-over-year to $1.2 million in Q4 2023; TTM through Dec 2023 was $5.6 million, a 72.82% increase from a year earlier, with the FY2023 full-year figure at $5.6 million, up 72.82% from the prior year.
- Interest & Investment Income fell to $1.2 million in Q4 2023 per QTTB's latest filing, from $1.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.7 million in Q2 2019 and bottomed at $11000.0 in Q4 2020.
- The 5-year median for Interest & Investment Income is $1.2 million (2020), against an average of $829700.0.
- Across the five-year window, Interest & Investment Income plunged 99.21% in 2020 and soared 4490.62% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $1.4 million in 2019, then plunged by 99.21% to $11000.0 in 2020, then soared by 281.82% to $42000.0 in 2021, then surged by 3364.29% to $1.5 million in 2022, then fell by 18.97% to $1.2 million in 2023.
- Per Business Quant, the three latest QTTB Interest & Investment Income figures stand at $1.2 million (Q4 2023), $1.4 million (Q3 2023), and $1.5 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 474,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 38,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 357,000.00 |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | 1.39 Mn |
| Sep 30, 2019 | 1.66 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Mar 31, 2019 | 1.27 Mn |